TESTOSTERONE: A SAFETY UPDATE 2025

[madman]

TESTOSTERONE: A SAFETY UPDATE (2025)

Prof. Michael Zitzmann

 

[madman]

Prof. Michael Zitzmann

SAC MEETING IN LONDON 2024​

In September 2024, Androlabs held a Scientific Advisory Committee (SAC) meeting in London, bringing together 17 of Europe's most prominent key opinion leaders in men's health and endocrinology to the Royal Society of Medicine. The SAC meeting provided a dynamic forum for open discussion and knowledge sharing, with a focus on testosterone therapy and its effects on men's health.

KEY DISCUSSIONS ON MEN’S HEALTH AND TESTOSTERONE THERAPY​

The meeting included in-depth discussions about key topics such as testosterone's cardiovascular safety, managing haematocrit responses to therapy, and understanding the efficacy of testosterone gels. Attendees agreed on several key points, including improved testosterone management education for healthcare providers. This discussion highlighted the importance of personalised care in testosterone therapy, as well as improving patient compliance during the first few months of treatment.




ANDROLABS SCIENTIFIC ADVISORY COMMITEE (2024)

 

[madman]

Thread 'Cardiovascular safety of testosterone therapy—Insights from the TRAVERSE trial and beyond'

May 16, 2025

7 FUTURE RESEARCH DIRECTIONS

While substantial progress has been made in understanding the CV safety of TTh, key areas for future research remain to further refine its application and optimize patient outcomes.


1. Long-term CV outcomes: The TRAVERSE trial and similar studies have reassured us of TTh’s short-to-medium-term CV safety, yet long-term effects, especially across diverse populations, require further investigation. Extended follow-up studies are needed to assess the potential for long-term CV safety in men undergoing decades-long TTh.


2. Personalized medicine...

• madman
• hypogonadism; t-therapy[ cvd; guidelines
• Replies: 3
• Forum: Testosterone and Men's Health Articles

 

[madman]

TESTOSTERONE THERAPY - A SAFETY UPDATE

Learning outcomes for today

 

[madman]

Target organs of testosterone and its metabolites

Hypothalamic-Pituitary-Gonadal Axis